Author: admin

Richard Francis, Teva’s President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time)

TEL AVIV, Israel, Jan. 11, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will present its ongoing transformation and expected growth trajectory through 2030 at the 44^th Annual J.P. Morgan Healthcare Conference. Teva’s President and Chief Executive Officer, Richard Francis, will meet with investors and present the Company’s milestones achieved in 2025, transformative initiatives, and forward-looking outlook for 2026 and beyond.

Presentation Highlights:

• Pivot to Growth Strategy Progress: Teva is accelerating its Pivot to Growth strategy, focusing on transforming into a leading innovative biopharmaceutical company through late-stage innovative pipeline, fueled by its world-class generics business.
• Innovation at the Heart of Teva’s Transformation: Teva’s key innovative brands – AUSTEDO^®, AJOVY^® and UZEDY^® – are already driving its growth and reshaping Teva’s financial outlook. Teva’s clinical pipeline assets – olanzapine LAI, DARI (ICS/SABA), duvakitug (anti-TL1A), emrusolmin, and anti-IL-15 – are expected to drive Teva’s long-term growth trajectory and further Teva’s transformation.
• 2025 Performance: Teva to provide its expected 2025 financial performance.
• 2026 and Beyond: In addition, Teva to provide forward-looking outlook for 2026 and beyond, underlining disciplined capital allocation and a commitment to securing an investment-grade credit rating.

Expected 2025 Performance

Path to achieving 2027 targets and additional 2030 targets

<sup>Note: 2026 commentary compared to 2025 results excluding duvakitug milestones, except for net debt leverage calculation.
* Revenues presented on a GAAP basis; all other metrics presented on a non-GAAP basis.
** Free Cash Flow includes cash flow generated from operating activities net of capital expenditures and deferred purchase price cash component collected for securitized trade receivables.</sup>

To access a live webcast of the presentation, visit Teva’s Investor Relations website at:  https://ir.tevapharm.com/Events-and-Presentations.

An archived version of the webcast will be available within 24 hours after the end of the live discussion and will be accessible for up to 30 days.

About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to better health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures as defined by SEC rules. Management believes that such non-GAAP financial measures provide useful information to investors to facilitate their understanding of our business because the non-GAAP financial measures are used by Teva’s management and board of directors, in conjunction with other performance metrics, to evaluate the operational performance of the company, to compare against the company’s work plans and budgets, and ultimately to evaluate the performance of management; the company’s annual budgets are prepared on a non-GAAP basis; and senior management’s annual compensation is derived, in part, using these non-GAAP measures. Investors should consider the non-GAAP financial measures in addition to, and not as replacements for, or superior to, measures of financial performance prepared in accordance with GAAP. In the case of the non-GAAP financial measures disclosed in this press release, we are not providing comparable forward looking guidance for GAAP financial measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measure because we are unable to predict with reasonable certainty the ultimate outcome of certain significant items including, but not limited to, the amortization of purchased intangible assets, legal settlements and loss contingencies, impairment of long-lived assets and goodwill impairment, without unreasonable effort. These items are uncertain, depend on various factors, and could be material to our results computed in accordance with GAAP.

Teva Cautionary Note Regarding Forward Looking Statements
This Press Release and the presentation at the conference may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding our financial guidance, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. These forward-looking statements include statements concerning our plans, strategies, objectives, future performance and financial and operating targets, and any other information that is not historical information. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe,” “outlook” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace, including: that we are substantially dependent on our generic products; our ability to develop and commercialize additional pharmaceutical products; competition for our innovative medicines; our ability to achieve expected results from investments in our product pipeline; our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; and the effectiveness of our patents and other measures to protect our intellectual property rights; our significant indebtedness, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this document, in our Quarterly Report on Form 10-Q for the third quarter of 2025 and in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned “Risk Factors” and “Forward-looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Samsung Electronics today announced the launch of “Help Me Choose,” a digital tool designed to guide consumers in selecting the ideal laundry solution based on their individual needs and lifestyle preferences.

With just a few clicks, the tool evaluates suitability across product types including washers, dryers, washer & dryer sets and all-in-one combos, empowering users to make smarter decisions based on real-time product recommendations.

“Today’s consumers have a wide array of laundry needs and preferences, and that means there is no one-size-fits-all solution,” said Sang Jik Lee, Executive Vice President and Head of Sales & Marketing Team for Digital Appliances (DA) Business at Samsung Electronics. “By simplifying the decision-making process and offering a more intuitive product discovery journey, the ‘Help Me Choose’ tool makes it easy to find the best fit.”

Designed for a Range of Modern Lifestyles

Samsung has continually expanded its washing machine portfolio to meet the needs of diverse markets and lifestyles — from compact models for people living alone to high-capacity appliances for larger households.

When consumers shopping online, however, the wide range of available models can sometimes make the selection process overwhelming. Reflecting the growing trend of online shopping for home appliances and the expanding variety of consumer lifestyles worldwide, the new tool guides users through a series of lifestyle-based questions, such as how big their household is, how often they do laundry in a week, how much space is available and what values, like energy or time saving, are most important to them. Based on these responses, users can receive tailored recommendations from Samsung’s lineup of washing machines available in their region.

For example, if someone lives alone, owns a pet and values space efficiency, the tool can recommend the Bespoke AI Laundry Combo. This is because it provides an efficient laundry experience by completing both washing and drying in a single unit, avoiding the need for two separate machines, while also offering the Pet Care and AI Wash & Dry¹ cycles.

Availability

Help Me Choose will roll out on Samsung.com in select global markets starting in January, with broader availability to follow.

Samsung also plans to expand the experience to additional product categories starting in the first half of 2026, helping consumers make confident, informed purchase decisions more conveniently.

by Bob Francis, Fort Worth Report
January 11, 2026

A record-setting number of Texas homes sold for $1 million or more from November 2024 to October 2025, according to the 2025 Texas Sales of Million-Dollar Homes Report released by the Texas Realtors association.

The 14,418 homes sold represent a 12% increase over the previous year. The $24.5 billion collective sales value of those homes is also a new record.

More homes in the $1 million+ price range were available in 2025, with 32,793 new listings, compared to 28,325 new listings in the previous year.

While 4.3% of all homes sold in Texas were $1 million+ homes, those properties made up 17.2% of all residential sales dollar volume in the state, an increase from 15.7% the previous year.

All four of the state’s largest metros had increases in $1 million+ home sales of at least 10%. The Houston area had the largest increase at 18%. The Dallas-Fort Worth area showed a 10% increase from November 2024 to the end of October 2025. 

Almost 90% of the $1 million+ homes sold in Texas last year were in one of the four largest metro areas. At 38%, Dallas-Fort Worth-Arlington had the largest share, with 5,485 homes worth a combined $9.7 billion. 

The average price per square foot of $1 million+ homes increased to $423 from $418 last year and was more than double the $188 average price per square foot of all Texas homes.

The median closing price for $1 million+ homes statewide was $1.37 million. Of the largest metro areas, the Dallas-Fort Worth area had the highest median closing price at $1.42 million. 

A recent noteworthy sale was a home once owned by the co-owner of the Texas Rangers. The home, a seven-bedroom estate located at 9553 Bella Terra Drive in Fort Worth’s upscale Montserrat neighborhood, sold for $6.8 million at auction. 

The home was previously listed for sale at $11.75 million. It went on the auction block on Dec. 3 with bidding ended Dec. 18. 

Horned Frog bobblehead 

Texas Christian University’s football season may be over with a last-minute nailbiting 30-27 victory over the University of Southern California in the Alamo Bowl, but the team’s bobbleheads live on. 

The National Bobblehead Hall of Fame and Museum has just released an officially licensed statuette of the Horned Frog mascot.

Each of the 2,025 bobbleheads being manufactured is individually numbered and costs $35 plus an $8 shipping charge. 

According to TCU, the Horned Frog mascot began life as “Addie the All-American Frog” in 1949 and became SuperFrog in 1979. In 1999, the mascot underwent a more radical transformation into the current look modeled by the bobblehead. 

Tandy gets handy 

Tandy Leather has opened its flagship store in Fort Worth’s West 7th corridor at 2973 Crockett St. 

The grand opening will be Jan. 24 for the store, which looks to pair Tandy’s century-old heritage with a modern, interactive store experience.

The company, which dates its history to 1919 and was part of Charles Tandy’s Tandy Corp. empire, last year announced the sale of its headquarters, including a store located at 1900 SE Loop 820, to food packaging company Colonna Brothers. 

Fort Worth firm secures capital 

Fort Worth-based Equify Financial has closed a $100 million preapproved credit arrangement with JPMorgan Chase & Co.

The funds will be used to support Equify’s growing portfolio of commercial loans, with a focus on equipment finance, asset-based lending, and structured solutions for operators in capital-intensive industries.

Fort Worth firm acquired

Atlanta-based White Cap, a distributor of specialty construction supplies and safety products for professional contractors, has acquired VoidForm Products, a manufacturer of products designed to protect concrete structures from damage caused by expansive, corrosive and seismic soil conditions. VoidForm Products has six locations across Texas, Colorado, Mississippi and Canada. 

David DiLuccia will continue to lead the VoidForm Products business. VoidForm had previously partnered with Argonaut Private Equity, a Tulsa-based private equity firm. 

Fort Worth seeking proposals 

The city of Fort Worth is currently seeking proposals from qualified firms or individuals with horizontal and vertical public works experience to finalize an exclusive agreement to provide professional services in developing and administering a Small Contractor Development Program.

The SCDP is intended to strengthen the capacity, competitiveness and performance of small, local, new and emerging businesses within Tarrant, Denton, Johnson, Parker and Wise counties. These businesses would help deliver water, transportation and other public works projects for the city.

The Small Contractor Development Program aims to:

• Provide training, mentorship and technical assistance.
• Support firms in understanding Texas-specific contracting requirements with Texas Department of Transportation, Texas Commission on Environmental Quality, Historically Underutilized Business and Fort Worth’s contracting requirements as well as the new Small Business Development Program.
• Identify and make recommendations regarding access to bonding, financing and compliance resources.

Identify additional “best value” subcontracting and prime contracting opportunities on municipal capital improvement projects for SCDP cohort member participation.

Proposals will be accepted through Jan. 29. 

Private equity firm makes investments 

Fort Worth and San Francisco-based TPG, a private equity firm, has made a series of investments and acquisitions of late. 

• TPG has agreed to acquire a majority stake in Conservice, a utility management platform for the property management industry. TPG will invest in Conservice through TPG Capital, the firm’s U.S. and European private equity platform, and will join leading global private equity investor Advent International, who will retain a significant stake after first investing in Conservice in 2020. 
• TPG Real Estate has acquired a majority interest in homebuilder Lennar Corp.’s Quarterra, a developer of multifamily communities. TPG has made an additional $1 billion strategic commitment in connection with the acquisition and expects to raise additional capital to fund future growth and the development of Quarterra’s multifamily pipeline. The partnership will focus on Quarterra’s Emblem communities, which looks to develop attainable rental housing options nationwide. 
• TPG and Jackson Financial established a long-term strategic investment management partnership with a minimum commitment to manage at least $12 billion in assets for Jackson. TPG will make a $500 million minority investment in Jackson while Jackson will receive $150 million in TPG shares. 

Do you have something for the Bob on Business column? Email Bob Francis, business editor for the Fort Worth Report, at bob.francis@fortworthreport.org.

At the Fort Worth Report, news decisions are made independently of our board members and financial supporters. Read more about our editorial independence policy here.

This <a target=”_blank” href=”https://fortworthreport.org/2026/01/11/bob-on-business-sales-of-1m-homes-set-record-in-2025/”>article</a> first appeared on <a target=”_blank” href=”https://fortworthreport.org”>Fort Worth Report</a> and is republished here under a <a target=”_blank” href=”https://creativecommons.org/licenses/by-nd/4.0/”>Creative Commons Attribution-NoDerivatives 4.0 International License</a>.<img src=”https://i0.wp.com/fortworthreport.org/wp-content/uploads/2021/04/cropped-favicon.png?resize=150%2C150&amp;quality=80&amp;ssl=1″ style=”width:1em;height:1em;margin-left:10px;”>

<img id=”republication-tracker-tool-source” src=”https://fortworthreport.org/?republication-pixel=true&post=362040&amp;ga4=2820184429″ style=”width:1px;height:1px;”><script> PARSELY = { autotrack: false, onload: function() { PARSELY.beacon.trackPageView({ url: “https://fortworthreport.org/2026/01/11/bob-on-business-sales-of-1m-homes-set-record-in-2025/”, urlref: window.location.href }); } } </script> <script id=”parsely-cfg” src=”//cdn.parsely.com/keys/fortworthreport.org/p.js”></script>